Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1291
interventional 1043
Observational 238
Registry 10

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 521
Behavioral 202
Drug|placebo 78
Other 51
Biological 47
Device 23
Behavioral|Other 18
Procedure 13
Biological|placebo 10
Dietary Supplement|placebo 10
Dietary Supplement 8
Combination Product 7
Diagnostic Test 7
Drug|Other 7
Behavioral|Drug 6
Device|Other 4
Drug|Other|placebo 3
Biological|Drug|placebo 2
Biological|Other 2
Dietary Supplement|Drug 2
Drug|Procedure 2
Behavioral|Biological 1
Behavioral|Device|Procedure 1
Behavioral|Diagnostic Test|Drug 1
Behavioral|Diagnostic Test|Procedure 1
Behavioral|Dietary Supplement 1
Behavioral|Other|Procedure 1
Behavioral|Procedure 1
Biological|Device 1
Biological|Drug 1
Biological|Drug|Other 1
Combination Product|Device 1
Combination Product|Drug 1
Combination Product|placebo 1
Device|Drug 1
Device|placebo 1
Dietary Supplement|Drug|placebo 1
Drug|Genetic 1
Drug|Radiation 1
Genetic 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 509
NA 71
United States|Puerto Rico 37
South Africa 31
Canada 20
Kenya 20
Uganda 20
United Kingdom 17
Thailand 15
Brazil 12
China 11
Spain 11
United States|Canada 10
France 9
Germany 8
Tanzania 8
Australia 7
Malawi 7
Switzerland 7
Lesotho 6
Mexico 6
Belgium 5
Mozambique 5
India 4
United States|Canada|Puerto Rico 4
Argentina 3
Botswana 3
Denmark 3
Ireland 3
Italy 3
Nigeria 3
Russian Federation 3
Senegal 3
Singapore 3
Taiwan 3
Vietnam 3
Zambia 3
Zimbabwe 3
Burkina Faso|Côte D’Ivoire|Mali|Togo 2
Cameroon 2
Estonia 2
Ethiopia 2
Ghana 2
Indonesia 2
Netherlands 2
Romania 2
Rwanda 2
Swaziland 2
United States|South Africa 2
United States|Tanzania 2
|United States|Italy|Puerto Rico 1
Argentina|Brazil|Canada|United Kingdom 1
Argentina|Brazil|India|Kenya|South Africa 1
Argentina|France|South Africa|United States|Thailand 1
Australia|Brazil|France|Poland|Russian Federation|Spain|Sweden|United Kingdom 1
Australia|France|Germany|Italy|Spain|United Kingdom 1
Australia|United States|American Samoa 1
Austria 1
Austria|Belgium|Denmark|France|Germany|Hungary|Ireland|Israel|Poland|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Ireland|Italy|Latvia|Netherlands|Portugal|Spain|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|Germany|Hungary|Israel|Portugal|Russian Federation|Spain|Switzerland|United Kingdom 1
Austria|Denmark|France|Germany|Hungary|Israel|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
Belgium|France|Germany|Ireland|Italy|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
Belgium|Netherlands 1
Brazil|Estonia|India|Thailand 1
Bulgaria 1
Cambodia 1
Cambodia|Thailand 1
Cameroon|Kenya|Senegal|South Africa|Thailand|Uganda 1
Chile|France|United States|Argentina|Australia|Austria|Brazil|Germany|Guatemala|Hungary|Malaysia|Panama|Puerto Rico|Romania|South Africa|Spain|Taiwan|Thailand|United Kingdom 1
China|Korea, Republic of 1
China|Korea, Republic of|Singapore 1
Congo, The Democratic Republic of the 1
Ecuador 1
France|Canada 1
Georgia 1
Germany|Ireland|Netherlands|Thailand|United Kingdom 1
Germany|Netherlands 1
Germany|United Kingdom 1
Haiti 1
India|Malawi|South Africa|Tanzania|Uganda|Zambia|Zimbabwe 1
India|South Africa|Uganda 1
Iran, Islamic Republic of 1
Israel 1
Italy|South Africa|Spain|Thailand 1
Italy|United States|France|Germany|South Africa|Spain 1
Jamaica 1
Japan 1
Kazakhstan 1
Kenya|Malawi|Rwanda|South Africa|Tanzania 1
Kenya|Malawi|Uganda|Zambia|Zimbabwe 1
Kenya|Malawi|Uganda|Zimbabwe 1
Kenya|Tanzania|Thailand|Uganda 1
Kenya|Zimbabwe 1
Korea, Republic of 1
Mauritius|Thailand 1
Nepal 1
Norway 1
Peru 1
Puerto Rico|United States 1
South Africa|Tanzania 1
South Africa|Tanzania|Uganda|Zambia 1
South Africa|Thailand|Ukraine 1
South Africa|Uganda|Zambia 1
South Africa|Uganda|Zimbabwe 1
South Africa|Zimbabwe 1
Spain|Sweden|Switzerland|Puerto Rico|United States|Belgium|Canada|France|Poland|United Kingdom 1
Sweden 1
Thailand|Argentina|Brazil|Mexico|Peru|Russian Federation|South Africa 1
Uganda|Zimbabwe 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Chile|Czechia|Denmark|Estonia|Finland|France|Germany|Greece|India|Ireland|Israel|Italy|Luxembourg|Malaysia|Mali|Mexico|Morocco|Nigeria|Norway|Peru|Poland|Portugal|Puerto Rico|South Africa|Spain|Sweden|Switzerland|Thailand|Uganda|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Denmark|France|Mexico|Netherlands|Portugal|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Sweden|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|France|Greece|Hungary|Italy|Mexico|Netherlands|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Romania|Russian Federation|South Africa|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|France|Germany|Italy|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Canada|France|Germany|Italy|Korea, Republic of|Mexico|Russian Federation|South Africa|Spain|Sweden 1
United States|Argentina|Austria|Brazil|China|France|Germany|Mexico|Puerto Rico|Russian Federation|South Africa|Thailand|Uganda|United Kingdom 1
United States|Argentina|Brazil|Puerto Rico|South Africa 1
United States|Argentina|Canada|France|Italy|Mexico|Portugal|Puerto Rico|Russian Federation|South Africa|Spain|Thailand|United Kingdom 1
United States|Argentina|Colombia|Germany|Mexico|Peru|Romania|Russian Federation|South Africa|Spain 1
United States|Argentina|France|Guatemala|Mexico|Peru|Puerto Rico|Romania|Russian Federation|South Africa|Ukraine 1
United States|Argentina|Mexico|Portugal|Puerto Rico|Russian Federation|South Africa 1
United States|Argentina|South Africa|Thailand|United Kingdom 1
United States|Australia 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Portugal|Puerto Rico|Spain|United Kingdom 1
United States|Australia|Austria|Canada|Dominican Republic|Germany|Mexico|Puerto Rico|United Kingdom 1
United States|Australia|Belgium|Canada|Czech Republic|France|Germany|Greece|Ireland|Italy|Netherlands|Poland|Puerto Rico|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Romania|Spain|United Kingdom 1
United States|Australia|Canada|Denmark|France|Germany|Italy|Sweden|Switzerland|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|Russian Federation|Spain|United Kingdom 1
United States|Australia|Canada|France|Puerto Rico 1
United States|Australia|Puerto Rico 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Latvia|Luxembourg|Poland|Portugal|Romania|Spain|Switzerland 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Portugal|Puerto Rico|Spain|Switzerland|United Kingdom 1
United States|Bahamas|Brazil|Puerto Rico 1
United States|Belgium|Canada|France|Germany|Italy|Portugal|Spain|United Kingdom 1
United States|Belgium|Canada|Romania|Russian Federation|South Africa|Spain 1
United States|Belgium|Dominican Republic|France|Italy|Mexico|Portugal|Puerto Rico|Russian Federation|Thailand|Uganda|United Kingdom 1
United States|Botswana 1
United States|Brazil|Chile|France|Italy|Portugal|Spain|United Kingdom 1
United States|Brazil|Italy|Mexico|Portugal|Puerto Rico|South Africa|Spain|Thailand 1
United States|Canada|France|Germany|Portugal|Puerto Rico|Spain|United Kingdom 1
United States|Canada|France|Germany|Spain 1
United States|Canada|France|Italy|Poland|Puerto Rico|Spain 1
United States|Canada|France|Italy|Spain 1
United States|Canada|Netherlands|Puerto Rico 1
United States|Costa Rica|Panama|Puerto Rico 1
United States|Denmark|Germany 1
United States|Dominican Republic|Russian Federation|Thailand|Uganda 1
United States|France|Germany|Italy|Puerto Rico|Romania|Russian Federation|Spain|Switzerland 1
United States|France|Germany|Italy|Russian Federation|Spain 1
United States|France|United Kingdom 1
United States|Germany 1
United States|Germany|Spain 1
United States|Italy 1
United States|Kazakhstan 1
United States|Kenya|Puerto Rico|South Africa 1
United States|Mexico 1
United States|Netherlands 1
United States|Puerto Rico|Tanzania 1
United States|Russian Federation 1
United States|Rwanda 1
United States|South Africa|Thailand 1
United States|South Africa|Thailand|Uganda|Zimbabwe 1
United States|South Africa|Zimbabwe 1
United States|Spain|Belgium|Canada|France|Italy|Portugal 1
United States|Uganda 1
United States|Zambia 1
Zimbabwe|United States|Malawi|South Africa|Zambia 1

Sites per Study

Site_count Study_Count
1 632
2 87
3 37
4 29
5 24
6 14
7 14
8 11
9 11
10 5
11 8
12 10
13 4
14 7
15 8
16 3
17 9
18 8
19 6
20 4
21 3
22 3
23 4
24 3
25 2
26 3
27 1
28 4
30 2
32 3
34 3
35 3
36 3
37 5
39 3
40 2
41 2
42 1
43 1
44 3
45 3
46 2
47 3
48 2
49 2
50 1
51 3
52 3
54 3
56 2
60 1
62 1
66 1
67 1
68 2
69 1
71 2
72 1
75 1
76 2
80 2
82 1
87 2
89 2
90 1
95 1
96 1
99 2
101 1
103 1
105 1
115 1
120 1
129 1
145 1
180 1
218 1

Phase

Phase Study_Count
N/A 378
Phase 1 224
Phase 2 162
Phase 3 148
Phase 4 80
Phase 1/Phase 2 27
Phase 2/Phase 3 18
Early Phase 1 6

Number of Arms

Number_of_Arms Count_of_Studies
1 179
2 420
3 85
4 46
5 17
6 9
7 2
8 4
9 4
10 1
11 2
12 1
13 1
14 1
15 1
18 1
21 1
NA 268

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.00000 4.0000 5.00000 10.00000 5.0000 30.000 1.0000 10.0000
1st Qu. 11.25000 70.0000 18.00000 20.00000 44.5000 63.500 146.7500 33.0000
Median 26.50000 229.0000 30.00000 30.00000 90.0000 157.500 313.0000 88.0000
Mean 60.83333 870.1471 43.02358 71.74074 225.2312 1385.833 716.7153 526.1266
3rd Qu. 66.50000 531.0000 48.00000 96.00000 179.0000 1786.000 645.5000 225.0000
Max. 220.00000 25000.0000 500.00000 333.00000 5029.0000 12000.000 10000.0000 18696.0000

Trial Group Type

group_type Group_Count
Experimental 1152
Active Comparator 312
NA 268
No Intervention 143
Placebo Comparator 114
Other 79
Sham Comparator 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 505
Single Group Assignment 231
NA 189
Crossover Assignment 79
Factorial Assignment 25
Sequential Assignment 14

Primary Purpose

primary_purpose Study_Count
Treatment 601
Prevention 196
Health Services Research 54
Supportive Care 50
Other 42
NA 37
Basic Science 35
Diagnostic 14
Screening 11
Device Feasibility 2
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
United States 87
NA 38
Thailand 8
Canada 6
France 6
Germany 6
Spain 6
Uganda 6
China 5
Brazil 4
Swaziland 4
Taiwan 4
United Kingdom 4
Ghana 3
Italy 3
Japan 3
Kenya 3
Korea, Republic of 3
Lesotho 3
South Africa 3
United States|Puerto Rico 3
United States|Canada 2
Argentina 1
Argentina|Brazil|Mexico 1
Australia 1
Cameroon|Kenya|Lesotho|Swaziland|Uganda 1
Ecuador|Peru 1
Ethiopia 1
Finland|Ireland|Netherlands|Portugal|Switzerland 1
Hong Kong 1
India 1
Indonesia 1
Israel 1
Kenya|South Africa 1
Netherlands 1
Nigeria 1
Poland 1
Russian Federation 1
Rwanda|South Africa 1
Switzerland 1
Tanzania 1
Uganda|Zimbabwe 1
United States|Australia|Brazil|Canada|Zimbabwe 1
United States|Belgium|Brazil|Canada|France|Germany|Greece|Italy|Puerto Rico|Spain|United Kingdom 1
United States|Brazil|Peru|South Africa 1
United States|India|Kenya|Thailand 1
United States|Malawi|South Africa|Tanzania|Uganda 1
Vietnam 1
Zambia 1
Zimbabwe 1

Sites per Study

Site_count Study_Count
1 172
2 8
3 8
4 6
5 6
6 2
7 1
8 6
9 4
10 2
11 1
12 3
13 1
14 1
15 2
17 1
18 2
19 1
20 2
21 1
23 2
29 1
30 1
34 1
38 1
90 1
267 1

Enrollment Metrics

Measure Observational
Min 0.0000
1st Qu 56.2500
Median 200.0000
Mean 986.8604
3rd Qu 531.0000
Max 40000.0000

Observation Model

observational_model Study_Count
Cohort 124
NA 51
Case-Only 20
Other 14
Case-Control 13
Case Control 12
Defined Population, Natural History 2
Natural History 2

Time Perspective

time_perspective Study_Count
Prospective 136
Cross-Sectional 35
NA 35
Retrospective 21
Other 8
Longitudinal, Prospective 2
Cross-Sectional, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
United States 3
Brazil 1
Ethiopia 1
France 1
Mexico 1
NA 1
Spain 1
Tanzania 1

Sites per Study

Site_count Study_Count
1 8
4 1
6 1

Enrollment Metrics

Measure Registries
Min 1.00
1st Qu 132.75
Median 353.00
Mean 903.40
3rd Qu 1147.50
Max 3760.00

Registry Model

observational_model Study_Count
Cohort 3
Ecologic or Community 3
Other 2
Case-Only 1
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 10

Follow-up

target_duration Study_Count
1 Year 2
1 Day 1
1 Month 1
12 Months 1
24 Months 1
3 Years 1
31 Years 1
6 Months 1
7 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03377608 Modifiers of Tenofovir in the Female Genital Tract https://ClinicalTrials.gov/show/NCT03377608 Completed University of Minnesota 2018-03-29
NCT04263207 Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV Reservoir https://ClinicalTrials.gov/show/NCT04263207 Recruiting Istituto Superiore di Sanità 2023-01-31
NCT03826160 Growth Hormone Dynamics and Cardiac Steatosis in HIV https://ClinicalTrials.gov/show/NCT03826160 Recruiting Massachusetts General Hospital 2021-01-30
NCT03334552 Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania. https://ClinicalTrials.gov/show/NCT03334552 Active, not recruiting Ludwig-Maximilians - University of Munich 2020-05-31
NCT03327740 PRJ2203: Dolutegravir Post Authorization Safety Study (PASS) https://ClinicalTrials.gov/show/NCT03327740 Completed ViiV Healthcare 2019-12-31
NCT03310515 Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT03310515 Completed ViiV Healthcare 2018-12-31
NCT03304912 Packaging PrEP to Prevent HIV Among WWID https://ClinicalTrials.gov/show/NCT03304912 Completed Drexel University 2019-10-08
NCT03300830 Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease https://ClinicalTrials.gov/show/NCT03300830 Recruiting National Institutes of Health Clinical Center (CC) 2037-06-07
NCT03290755 Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux https://ClinicalTrials.gov/show/NCT03290755 Completed University Hospital, Bordeaux 2018-03-13
NCT03284645 Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids https://ClinicalTrials.gov/show/NCT03284645 Active, not recruiting Obafemi Awolowo University 2020-11-30
NCT03279185 Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite https://ClinicalTrials.gov/show/NCT03279185 Recruiting Harvard School of Public Health 2023-10-01
NCT03249493 Monitoring Of Viral Load In Decentralised Area in Vietnam https://ClinicalTrials.gov/show/NCT03249493 Recruiting Institut Pasteur 2020-08-15
NCT03235518 A Combination HIV Prevention Strategy for Young Women at Risk for HIV https://ClinicalTrials.gov/show/NCT03235518 Active, not recruiting Columbia University 2018-03-30
NCT03215004 Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals https://ClinicalTrials.gov/show/NCT03215004 Recruiting American Gene Technologies International Inc. 2021-02-07
NCT03205696 Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection https://ClinicalTrials.gov/show/NCT03205696 Recruiting University of California, Los Angeles 2020-02-20
NCT03191175 Inflammasome Activation Via Circulating Metabolites https://ClinicalTrials.gov/show/NCT03191175 Completed University Hospital, Bordeaux 2017-12-20
NCT03190317 Health Information for Infected Veterans https://ClinicalTrials.gov/show/NCT03190317 Active, not recruiting VA Office of Research and Development 2019-12-16
NCT03100643 Development of a Couple-Based Mobile Health Intervention for Enhancing HIV Care Engagement Outcomes (N’Gage) https://ClinicalTrials.gov/show/NCT03100643 Completed University of California, San Francisco 2020-01-31
NCT03049891 Pediatric Decentralization of ART in South Africa https://ClinicalTrials.gov/show/NCT03049891 Completed Columbia University 2016-03-31
NCT02969161 Safe Generations Plus: Swaziland PMTCT LTF Study https://ClinicalTrials.gov/show/NCT02969161 Completed Columbia University 2017-05-31
NCT02926456 Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta) https://ClinicalTrials.gov/show/NCT02926456 Completed Janssen-Cilag S.p.A. 2018-02-14
NCT02886416 Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity https://ClinicalTrials.gov/show/NCT02886416 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2017-04-30
NCT02873741 New Strategies to Assess Anal Cancer Risk In Women https://ClinicalTrials.gov/show/NCT02873741 Completed Emory University 2017-02-27
NCT02804724 Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study https://ClinicalTrials.gov/show/NCT02804724 Completed University of Aberdeen 2015-08-31
NCT02650024 Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes https://ClinicalTrials.gov/show/NCT02650024 Recruiting University of California, San Diego 2020-07-31
NCT02638493 The Compartmental Biology of HIV in the Male Genital Tract https://ClinicalTrials.gov/show/NCT02638493 Completed University of North Carolina, Chapel Hill 2016-10-31
NCT02586584 The I-Score Study: Developing a New Patient-Reported Tool for the Routine HIV Care of Patients on Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT02586584 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2021-04-30
NCT02553369 Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection https://ClinicalTrials.gov/show/NCT02553369 Completed University Hospital Center of Martinique 2015-10-31
NCT02542020 Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis https://ClinicalTrials.gov/show/NCT02542020 Recruiting Oswaldo Cruz Foundation 2020-05-31
NCT02532348 Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection https://ClinicalTrials.gov/show/NCT02532348 Completed Centre Hospitalier Universitaire de Saint Etienne 2014-09-30
NCT02526940 Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men https://ClinicalTrials.gov/show/NCT02526940 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-08-31
NCT02514707 Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral Treatment https://ClinicalTrials.gov/show/NCT02514707 Recruiting Makerere University 2025-01-31
NCT02530827 Energy Expenditure of People Living With HIV/AIDS https://ClinicalTrials.gov/show/NCT02530827 Completed University of Sao Paulo General Hospital 2014-06-30
NCT02461576 Clinical Evaluation of the Xpert® HIV-1 VL https://ClinicalTrials.gov/show/NCT02461576 Completed Cepheid 2017-02-24
NCT02426866 Risk of CV Events With EFV vs. EFV-free Regimens https://ClinicalTrials.gov/show/NCT02426866 Completed Bristol-Myers Squibb 2015-01-31
NCT02399384 Pericardial Fat and Inflammation in HIV Patients and Controls https://ClinicalTrials.gov/show/NCT02399384 Completed University of Cincinnati 2018-07-01
NCT02396355 Accuracy Evaluation of the BD FACS Presto System https://ClinicalTrials.gov/show/NCT02396355 Completed Becton, Dickinson and Company 2015-05-31
NCT02027714 Enhanced HIV Prevention in Couples: Feasibility Study #1 https://ClinicalTrials.gov/show/NCT02027714 Completed Columbia University 2014-05-31
NCT02344680 Liver Fibrosis in Zambian HIV-HBV Co-infected Patients https://ClinicalTrials.gov/show/NCT02344680 Active, not recruiting University of Alabama at Birmingham 2024-08-31
NCT02322827 Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART https://ClinicalTrials.gov/show/NCT02322827 Completed Triple O Research Institute PA 2016-10-31
NCT02027519 Enhanced HIV Prevention in Couples: Feasibility Study #3 https://ClinicalTrials.gov/show/NCT02027519 Completed Columbia University 2014-05-31
NCT02027480 Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study https://ClinicalTrials.gov/show/NCT02027480 Completed Columbia University 2015-10-31
NCT02285478 Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected Children https://ClinicalTrials.gov/show/NCT02285478 Completed Radboud University 2016-07-31
NCT02027441 Enhanced Prevention in Couples: Feasibility Study #2 https://ClinicalTrials.gov/show/NCT02027441 Completed Columbia University 2013-08-31
NCT02247999 Improving Cervical Cancer Screening Among HIV-Infected Women in India https://ClinicalTrials.gov/show/NCT02247999 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02218320 Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults https://ClinicalTrials.gov/show/NCT02218320 Completed University of North Carolina, Chapel Hill 2015-10-31
NCT02196064 Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the “The HEPAVIR HEPATIC SAFETY Cohort.” https://ClinicalTrials.gov/show/NCT02196064 Completed Andalusian Network for Design and Translation of Advanced Therapies 2015-07-31
NCT02191215 Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS https://ClinicalTrials.gov/show/NCT02191215 Completed Boehringer Ingelheim 2004-05-31
NCT02166502 Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection https://ClinicalTrials.gov/show/NCT02166502 Completed The Hospital for Sick Children 2015-05-31
NCT02134431 Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents https://ClinicalTrials.gov/show/NCT02134431 Completed University of California, Los Angeles 2015-06-30
NCT02119702 Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) https://ClinicalTrials.gov/show/NCT02119702 Recruiting Harvard School of Public Health 2020-07-31
NCT02113865 Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients https://ClinicalTrials.gov/show/NCT02113865 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2014-10-31
NCT02098525 Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT02098525 Completed Mahidol University 2013-12-31
NCT02076386 A Prospective, Non-interventional Study of the Use of Dolutegravir as Part of Combination Antiretroviral Therapy in Routine Daily Practice in Germany https://ClinicalTrials.gov/show/NCT02076386 Completed ViiV Healthcare 2017-07-05
NCT01297127 Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection https://ClinicalTrials.gov/show/NCT01297127 Completed Hoffmann-La Roche 2013-09-30
NCT02057003 Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients https://ClinicalTrials.gov/show/NCT02057003 Recruiting Valme University Hospital 2020-12-31
NCT02043769 Pediatric Enhanced Surveillance Study https://ClinicalTrials.gov/show/NCT02043769 Completed Columbia University 2015-10-31
NCT02012621 Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT02012621 Completed University of Colorado, Denver 2017-07-31
NCT02006914 Novel Therapy for Glucose Intolerance in HIV Disease https://ClinicalTrials.gov/show/NCT02006914 Completed Stony Brook University 2010-05-31
NCT01997346 Multi-level Determinants of Starting ART Late: Aim 2 https://ClinicalTrials.gov/show/NCT01997346 Completed Columbia University 2011-12-31
NCT01976715 Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT01976715 Recruiting National Institutes of Health Clinical Center (CC) 2025-08-01
NCT01966094 Observational Study of HIV-associated Neurocognitive Disorder https://ClinicalTrials.gov/show/NCT01966094 Completed Emory University 2018-06-05
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01924455 HBV-HIV Coinfection Research Network https://ClinicalTrials.gov/show/NCT01924455 Completed Virginia Commonwealth University 2019-03-31
NCT01891799 Swaziland Safe Generations https://ClinicalTrials.gov/show/NCT01891799 Completed Columbia University 2016-10-30
NCT01869010 Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection https://ClinicalTrials.gov/show/NCT01869010 Completed Hospital Italiano de Buenos Aires 2012-03-31
NCT01849393 Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents https://ClinicalTrials.gov/show/NCT01849393 Completed St. Jude Children’s Research Hospital 2013-12-31
NCT01749007 Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS https://ClinicalTrials.gov/show/NCT01749007 Completed VA Eastern Colorado Health Care System 2016-08-31
NCT01748968 Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence https://ClinicalTrials.gov/show/NCT01748968 Completed VA Eastern Colorado Health Care System 2015-09-30
NCT01741844 A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence https://ClinicalTrials.gov/show/NCT01741844 Completed Janssen Korea, Ltd., Korea 2014-07-31
NCT01741831 A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista https://ClinicalTrials.gov/show/NCT01741831 Completed Janssen Korea, Ltd., Korea 2016-10-31
NCT01673750 Body Image in Youth With HIV https://ClinicalTrials.gov/show/NCT01673750 Completed St. Jude Children’s Research Hospital 2013-12-31
NCT01679067 Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients https://ClinicalTrials.gov/show/NCT01679067 Completed University of Cologne 2013-06-30
NCT01669954 Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study https://ClinicalTrials.gov/show/NCT01669954 Completed King’s College London 2012-05-31
NCT01662336 Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program https://ClinicalTrials.gov/show/NCT01662336 Completed AbbVie 2016-06-30
NCT01638312 Development of Method of Fructose Identification in Urine to Detect the Viral Infection https://ClinicalTrials.gov/show/NCT01638312 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2013-05-31
NCT01616823 Fetal HIV Transmission Risk and Duration of Membrane Rupture https://ClinicalTrials.gov/show/NCT01616823 Completed St. Michael’s Hospital, Toronto 2009-12-31
NCT01615601 An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT01615601 Completed Janssen Inc. 2013-04-30
NCT01613157 Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression https://ClinicalTrials.gov/show/NCT01613157 Completed Canadian Immunodeficiency Research Collaborative 2009-01-31
NCT01596322 International HIV Antiretroviral Adherence, Resistance and Survival https://ClinicalTrials.gov/show/NCT01596322 Completed Massachusetts General Hospital 2015-09-30
NCT01541085 An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART https://ClinicalTrials.gov/show/NCT01541085 Completed Janssen-Cilag S.p.A. 2013-06-30
NCT01507142 Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients https://ClinicalTrials.gov/show/NCT01507142 Completed Gaia Medical Institute 2012-09-30
NCT01492842 Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV https://ClinicalTrials.gov/show/NCT01492842 Completed University of North Carolina, Chapel Hill 2012-06-30
NCT01490346 Tissue Drug Levels of HIV Medications https://ClinicalTrials.gov/show/NCT01490346 Completed University of Minnesota 2014-09-30
NCT01460433 Problems With Immune Recovery in the Gut Tissue https://ClinicalTrials.gov/show/NCT01460433 Completed University of Minnesota 2013-01-31
NCT01450059 Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section https://ClinicalTrials.gov/show/NCT01450059 Completed Johann Wolfgang Goethe University Hospital 2014-04-30
NCT01447680 Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing https://ClinicalTrials.gov/show/NCT01447680 Completed G & W Laboratories Inc. 2012-12-31
NCT03348449 Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi) https://ClinicalTrials.gov/show/NCT03348449 Completed Asociacion para el Estudio de las Enfermedades Infecciosas 2018-06-15
NCT01418014 Adolescent Master Protocol https://ClinicalTrials.gov/show/NCT01418014 Active, not recruiting Harvard School of Public Health 2020-07-31
NCT01383005 Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets) https://ClinicalTrials.gov/show/NCT01383005 Completed AbbVie 2011-12-31
NCT01381029 Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals https://ClinicalTrials.gov/show/NCT01381029 Completed George Washington University 2014-08-31
NCT01377272 Spatial Epidemiology of HIV Infection https://ClinicalTrials.gov/show/NCT01377272 Completed National Taiwan University Hospital 2009-06-30
NCT01328158 Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection https://ClinicalTrials.gov/show/NCT01328158 Completed AbbVie 2013-12-31
NCT04276935 Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions https://ClinicalTrials.gov/show/NCT04276935 Completed AIDS Malignancy Consortium 2020-03-01
NCT01322217 Managerial Database II https://ClinicalTrials.gov/show/NCT01322217 Completed University of North Carolina, Chapel Hill 2012-06-30
NCT04439448 Adipose Tissue and Immune Activation in HIV https://ClinicalTrials.gov/show/NCT04439448 Completed Vanderbilt University Medical Center 2014-11-03
NCT04367688 HIV Pre-exposure Prophylaxis Implementation Hong Kong Study https://ClinicalTrials.gov/show/NCT04367688 Recruiting Chinese University of Hong Kong 2022-09-30
NCT04296331 HIV Jail POC-AgAB Testings https://ClinicalTrials.gov/show/NCT04296331 Recruiting Montefiore Medical Center 2020-03-13
NCT04215926 NAFLD in HIV-infected Patients https://ClinicalTrials.gov/show/NCT04215926 Recruiting Shanghai Public Health Clinical Center 2020-10-30
NCT04206878 Evaluating the Feasibility of Point of Care Birth Testing in Eswatini https://ClinicalTrials.gov/show/NCT04206878 Enrolling by invitation Elizabeth Glaser Pediatric AIDS Foundation 2020-06-30
NCT04206241 Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe https://ClinicalTrials.gov/show/NCT04206241 Enrolling by invitation Elizabeth Glaser Pediatric AIDS Foundation 2020-06-30
NCT04194021 Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir https://ClinicalTrials.gov/show/NCT04194021 Recruiting Elizabeth Glaser Pediatric AIDS Foundation 2021-12-31
NCT04138199 A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation https://ClinicalTrials.gov/show/NCT04138199 Active, not recruiting AbbVie 2021-01-20
NCT04117984 Swaziland HIV Incidence Measurement Survey 2 https://ClinicalTrials.gov/show/NCT04117984 Active, not recruiting Columbia University 2017-12-31
NCT04089488 Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America https://ClinicalTrials.gov/show/NCT04089488 Recruiting AIDS Malignancy Consortium 2020-12-01
NCT04077138 Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Intervention Development https://ClinicalTrials.gov/show/NCT04077138 Enrolling by invitation Hektoen Institute for Medical Research 2020-05-30
NCT04070248 Determining Bacterial Communities in the Lungs of HIV-infected Individuals With COPD in Uganda. https://ClinicalTrials.gov/show/NCT04070248 Recruiting Makerere University 2020-02-29
NCT04065347 Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF) https://ClinicalTrials.gov/show/NCT04065347 Recruiting University of Colorado, Denver 2025-07-31
NCT03984552 Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children https://ClinicalTrials.gov/show/NCT03984552 Recruiting The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 2020-06-05
NCT03922269 Trans People Living With HIV Throughout Europe https://ClinicalTrials.gov/show/NCT03922269 Recruiting Chelsea and Westminster NHS Foundation Trust 2021-06-30
NCT03884673 Dolutegravir Plus Lamivudine Simplified Therapy https://ClinicalTrials.gov/show/NCT03884673 Recruiting Guangzhou 8th People’s Hospital 2021-12-31
NCT03800407 Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection https://ClinicalTrials.gov/show/NCT03800407 Recruiting University of Florida 2023-01-31
NCT03800394 Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents https://ClinicalTrials.gov/show/NCT03800394 Recruiting University of Florida 2022-08-31
NCT03800381 Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet https://ClinicalTrials.gov/show/NCT03800381 Recruiting University of Florida 2022-08-30
NCT03790501 Impact of Physical Activity and Diet on Symptom Experience in People Living With HIV https://ClinicalTrials.gov/show/NCT03790501 Recruiting Case Western Reserve University 2023-04-30
NCT03789968 The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients https://ClinicalTrials.gov/show/NCT03789968 Enrolling by invitation Thomas Jefferson University 2020-02-28
NCT03777371 Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation https://ClinicalTrials.gov/show/NCT03777371 Completed Kanuni Sultan Suleyman Training and Research Hospital 2018-12-01
NCT03775083 What Happens in Vegas: PEP to PrEP Opportunities https://ClinicalTrials.gov/show/NCT03775083 Recruiting Huntridge Family Clinic 2019-08-31
NCT03747003 Gonadal Function in Young to Middle Aged HIV-infected Men https://ClinicalTrials.gov/show/NCT03747003 Active, not recruiting Azienda Ospedaliero-Universitaria di Modena 2017-12-31
NCT03603977 Simplified Treatment of Anti-retrovirus in China (C-STAR) https://ClinicalTrials.gov/show/NCT03603977 Recruiting Guangzhou 8th People’s Hospital 2020-12-31
NCT03583138 HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) https://ClinicalTrials.gov/show/NCT03583138 Completed Yale University 2015-12-15
NCT03577470 An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate https://ClinicalTrials.gov/show/NCT03577470 Active, not recruiting Janssen-Cilag S.p.A. 2020-07-31
NCT03575143 Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living With HIV https://ClinicalTrials.gov/show/NCT03575143 Recruiting University of California, San Diego 2022-07-15
NCT03558438 Spanish Cohort of Patients With HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function https://ClinicalTrials.gov/show/NCT03558438 Active, not recruiting Fundacion SEIMC-GESIDA 2023-05-31
NCT03490058 The Prevention Options for Women Evaluation Research (POWER) Cohort https://ClinicalTrials.gov/show/NCT03490058 Recruiting University of Washington 2020-07-01
NCT03489421 Mitochondria in HIV and Aging (MITO+) https://ClinicalTrials.gov/show/NCT03489421 Completed University of Colorado, Denver 2019-09-05
NCT03429842 HIV Awal (Early) Testing & Treatment Indonesia Project Observational Phase https://ClinicalTrials.gov/show/NCT03429842 Completed Gadjah Mada University 2017-12-31
NCT01261221 Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans https://ClinicalTrials.gov/show/NCT01261221 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2011-07-31
NCT01261208 The Study of the Prevalence of Helicobacter Pylori Infection Among HIV/AIDS Cohort https://ClinicalTrials.gov/show/NCT01261208 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2010-05-31
NCT01213316 A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen) https://ClinicalTrials.gov/show/NCT01213316 Completed Merck Sharp & Dohme Corp. 2015-04-30
NCT01210924 Chinese Network of Pediatric Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT01210924 Completed National Center for AIDS/STD Control and Prevention, China CDC 2015-12-31
NCT01206933 The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System https://ClinicalTrials.gov/show/NCT01206933 Completed George Washington University 2015-06-30
NCT01205243 ZIAGEN® Post-marketing Surveillance https://ClinicalTrials.gov/show/NCT01205243 Completed ViiV Healthcare 2015-02-01
NCT01180075 Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population https://ClinicalTrials.gov/show/NCT01180075 Completed University of North Carolina, Chapel Hill 2014-08-31
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients https://ClinicalTrials.gov/show/NCT01153269 Completed Abbott 2010-11-30
NCT01140633 Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda https://ClinicalTrials.gov/show/NCT01140633 Completed Massachusetts General Hospital 2011-01-31
NCT01097655 Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet https://ClinicalTrials.gov/show/NCT01097655 Completed AbbVie 2016-01-31
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term https://ClinicalTrials.gov/show/NCT01083810 Completed Abbott 2010-06-30
NCT01076985 Special Investigation of Kaletra in Pregnant Women https://ClinicalTrials.gov/show/NCT01076985 Completed Abbott 2010-12-31
NCT01076972 Drug Use Investigation of Kaletra https://ClinicalTrials.gov/show/NCT01076972 Completed Abbott 2010-12-31
NCT01077635 PENTA Fosamprenavir Study https://ClinicalTrials.gov/show/NCT01077635 Completed ViiV Healthcare 2011-09-30
NCT01076179 Kaletra in Combination With Antiretroviral Agents https://ClinicalTrials.gov/show/NCT01076179 Completed AbbVie 2016-01-31
NCT01077557 Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status https://ClinicalTrials.gov/show/NCT01077557 Completed ViiV Healthcare 2011-11-30
NCT01075191 Kaletra: Therapy With Double Protease Inhibitors https://ClinicalTrials.gov/show/NCT01075191 Completed AbbVie 2011-09-30
NCT01054638 HIV Treatment and CVD Events https://ClinicalTrials.gov/show/NCT01054638 Completed ViiV Healthcare 2010-12-31
NCT01054586 Fosamprenavir in Pts With Hepatic Impairment https://ClinicalTrials.gov/show/NCT01054586 Completed GlaxoSmithKline 2012-03-31
NCT01038999 Accelerated Aging, HIV Infection, Antiretroviral Therapies https://ClinicalTrials.gov/show/NCT01038999 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2010-04-30
NCT01002612 Reassessment of the Nutritional Status in Thai Orphans Living With HIV in a Family Style Community https://ClinicalTrials.gov/show/NCT01002612 Completed Thai Red Cross AIDS Research Centre 2008-08-31
NCT01020045 Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis https://ClinicalTrials.gov/show/NCT01020045 Completed Emory University 2013-05-31
NCT00989144 Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort https://ClinicalTrials.gov/show/NCT00989144 Completed Thai Red Cross AIDS Research Centre 2008-10-31
NCT00981279 Profile of HIV Seropositive Patients https://ClinicalTrials.gov/show/NCT00981279 Completed Universidade Federal de Goias 2009-09-30
NCT00973466 Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients https://ClinicalTrials.gov/show/NCT00973466 Completed University Hospital Inselspital, Berne 2010-05-31
NCT00935935 Study of Bone Disease in Older HIV-infected Adults https://ClinicalTrials.gov/show/NCT00935935 Completed Ruth M. Rothstein CORE Center 2011-02-28
NCT00914225 Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya https://ClinicalTrials.gov/show/NCT00914225 Completed University of Washington 2011-12-31
NCT00886990 Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens https://ClinicalTrials.gov/show/NCT00886990 Completed The HIV Netherlands Australia Thailand Research Collaboration 2009-04-30
NCT00871078 Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients https://ClinicalTrials.gov/show/NCT00871078 Completed Federal University of São Paulo 2009-09-30
NCT00846599 Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men https://ClinicalTrials.gov/show/NCT00846599 Completed Tufts University 2010-01-31
NCT00845013 Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT00845013 Active, not recruiting University of California, San Francisco 2020-09-30
NCT00841360 ID and Testing Via Friendship Networks https://ClinicalTrials.gov/show/NCT00841360 Completed University of North Carolina, Chapel Hill 2010-06-30
NCT02191332 Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen https://ClinicalTrials.gov/show/NCT02191332 Completed Boehringer Ingelheim 2001-11-30
NCT01618058 Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials https://ClinicalTrials.gov/show/NCT01618058 Completed International Partnership for Microbicides, Inc. 2019-08-06
NCT04147832 Epividian / AHF: Positive Pathways - HIV Retention in Care https://ClinicalTrials.gov/show/NCT04147832 Enrolling by invitation Epividian 2021-04-30
NCT04179344 Usability Study of IeHS in Indonesia https://ClinicalTrials.gov/show/NCT04179344 Completed Bekasi City Public Hospital 2019-10-31
NCT03595956 Transgender Cohort Study of Gender Affirmation and HIV-related Health https://ClinicalTrials.gov/show/NCT03595956 Enrolling by invitation Fenway Community Health 2020-10-31
NCT00810446 Safety And Efficacy Of Rifabutin In HIV Patients https://ClinicalTrials.gov/show/NCT00810446 Completed Pfizer 2018-03-31
NCT01042808 Isentress Re-examination Study (MK-0518-115) https://ClinicalTrials.gov/show/NCT01042808 Completed Merck Sharp & Dohme Corp. 2014-05-31
NCT00749840 Attitudes and Beliefs and the Steps of HIV Care https://ClinicalTrials.gov/show/NCT00749840 Completed M.D. Anderson Cancer Center 2012-11-30
NCT00729573 Bone Mineral Density Substudy - An Ancillary Study to MTN-003 https://ClinicalTrials.gov/show/NCT00729573 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-05-31
NCT00666055 Sex, Aging and Antiretroviral Pharmacokinetics https://ClinicalTrials.gov/show/NCT00666055 Completed University of North Carolina, Chapel Hill 2012-05-31
NCT00675766 Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences https://ClinicalTrials.gov/show/NCT00675766 Completed VA Office of Research and Development 2011-02-28
NCT00665561 Prospective Observational Epidemiologic Study of Maraviroc’s Safety https://ClinicalTrials.gov/show/NCT00665561 Completed ViiV Healthcare 2019-02-14
NCT00551655 Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00551655 Completed AIDS Arms Inc. NA
NCT00511056 Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00511056 Completed The HIV Netherlands Australia Thailand Research Collaboration 2009-01-31
NCT00491335 HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers https://ClinicalTrials.gov/show/NCT00491335 Completed National Institutes of Health Clinical Center (CC) NA
NCT00481390 Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients https://ClinicalTrials.gov/show/NCT00481390 Completed GlaxoSmithKline 2007-12-31
NCT00476606 A Prospective Cohort of Children With HIV Infection https://ClinicalTrials.gov/show/NCT00476606 Recruiting The HIV Netherlands Australia Thailand Research Collaboration 2030-12-31
NCT00453440 Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 https://ClinicalTrials.gov/show/NCT00453440 Completed ViiV Healthcare 2007-08-10
NCT00434070 Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring https://ClinicalTrials.gov/show/NCT00434070 Completed National Institutes of Health Clinical Center (CC) NA
NCT00411983 A Long-term Follow-up of the HIV-NAT Cohort https://ClinicalTrials.gov/show/NCT00411983 Recruiting The HIV Netherlands Australia Thailand Research Collaboration 2030-12-31
NCT00394004 Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials https://ClinicalTrials.gov/show/NCT00394004 Completed National Institutes of Health Clinical Center (CC) NA
NCT00393302 HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy https://ClinicalTrials.gov/show/NCT00393302 Completed St. Michael’s Hospital, Toronto 2006-01-31
NCT00333892 Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients https://ClinicalTrials.gov/show/NCT00333892 Completed Canadian Immunodeficiency Research Collaborative NA
NCT00312468 Examining the Link Between Heart Disease and HIV Infection in Women https://ClinicalTrials.gov/show/NCT00312468 Completed Albert Einstein College of Medicine 2012-12-31
NCT00296660 Acute HIV Infection Observational Study https://ClinicalTrials.gov/show/NCT00296660 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-06-30
NCT00279331 Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador https://ClinicalTrials.gov/show/NCT00279331 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00270764 Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults https://ClinicalTrials.gov/show/NCT00270764 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-06-30
NCT00273273 PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir https://ClinicalTrials.gov/show/NCT00273273 Completed University of North Carolina, Chapel Hill 2007-12-31
NCT00245531 Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs https://ClinicalTrials.gov/show/NCT00245531 Completed Johns Hopkins University 2010-06-30
NCT00244803 Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2) https://ClinicalTrials.gov/show/NCT00244803 Completed Johns Hopkins University 2007-05-31
NCT00238459 Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised https://ClinicalTrials.gov/show/NCT00238459 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-03-31
NCT00219934 Observational Study of Treated and Untreated Acute and Early HIV-1 Infection https://ClinicalTrials.gov/show/NCT00219934 Completed Rockefeller University 2010-11-30
NCT00183287 Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials https://ClinicalTrials.gov/show/NCT00183287 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00168233 Impact of HIV and Its Treatment on Reverse Cholesterol Transport https://ClinicalTrials.gov/show/NCT00168233 Completed The Alfred 2010-09-30
NCT00159068 Analysis of Genetic Factors Which May Influence the Course of HIV Infection https://ClinicalTrials.gov/show/NCT00159068 Completed Hadassah Medical Organization 2011-04-30
NCT00122902 Spirituality and Will to Live in Patients With HIV/AIDS https://ClinicalTrials.gov/show/NCT00122902 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00097006 Retrovirus Epidemiology Donor Study-II (REDS-II) https://ClinicalTrials.gov/show/NCT00097006 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-09-30
NCT00091884 Efficacy of Elevated CD4 Counts on CMV Retinitis https://ClinicalTrials.gov/show/NCT00091884 Completed National Institutes of Health Clinical Center (CC) NA
NCT00086372 Long-term Follow-up of HIV Infected Patients Identified During Early Infection https://ClinicalTrials.gov/show/NCT00086372 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00075153 Quality of Life in Children With HIV Infection https://ClinicalTrials.gov/show/NCT00075153 Completed Rutgers, The State University of New Jersey 2008-07-31
NCT00073229 Immune Function of Infants With HIV https://ClinicalTrials.gov/show/NCT00073229 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2005-06-30
NCT00068978 Analysis of Immune Responses to HIV Vaccines https://ClinicalTrials.gov/show/NCT00068978 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001699 A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers https://ClinicalTrials.gov/show/NCT00001699 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001448 The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection https://ClinicalTrials.gov/show/NCT00001448 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001435 Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children https://ClinicalTrials.gov/show/NCT00001435 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001424 Evaluation and Natural History of Children With Cancer and AIDS https://ClinicalTrials.gov/show/NCT00001424 Completed National Institutes of Health Clinical Center (CC) NA
NCT00050284 Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection https://ClinicalTrials.gov/show/NCT00050284 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00025922 Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load https://ClinicalTrials.gov/show/NCT00025922 Completed National Institutes of Health Clinical Center (CC) NA
NCT00029913 A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials https://ClinicalTrials.gov/show/NCT00029913 Completed HIV Vaccine Trials Network 2009-07-31
NCT00017771 Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs https://ClinicalTrials.gov/show/NCT00017771 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00006440 A Test of Behavioral Intervention for Women at High Risk for HIV Infection https://ClinicalTrials.gov/show/NCT00006440 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-05-31
NCT00005020 Observing Patients With Early HIV Infection https://ClinicalTrials.gov/show/NCT00005020 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00796146 Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population https://ClinicalTrials.gov/show/NCT00796146 Recruiting South East Asia Research Collaboration with Hawaii 2033-07-31
NCT00001130 Identifying Emergency Room Patients Who Have Recently Been Infected With HIV https://ClinicalTrials.gov/show/NCT00001130 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001120 A Study of Patients With AIDS Syndrome https://ClinicalTrials.gov/show/NCT00001120 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001093 Outcomes of Anti-HIV Therapy During Early HIV Infection https://ClinicalTrials.gov/show/NCT00001093 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000911 A Study to Monitor Patients With Primary or Early HIV Infection https://ClinicalTrials.gov/show/NCT00000911 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-06-30
NCT00000930 A Study of HIV in Newly Infected Individuals https://ClinicalTrials.gov/show/NCT00000930 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-05-31
NCT00000858 Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections https://ClinicalTrials.gov/show/NCT00000858 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00006310 KSHV Infection in Blood Donors From Texas https://ClinicalTrials.gov/show/NCT00006310 Completed The University of Texas Health Science Center at San Antonio NA
NCT00055094 Treatment of Acute HIV Infection to Preserve Immune Function https://ClinicalTrials.gov/show/NCT00055094 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00005360 HIV Diversity and Pathogenesis in Donor-Recipient Clusters https://ClinicalTrials.gov/show/NCT00005360 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005353 Cardiac Autonomic Control in Children of HIV Positive Mothers https://ClinicalTrials.gov/show/NCT00005353 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005379 Tuberculosis in a Multiethnic Inner City Population https://ClinicalTrials.gov/show/NCT00005379 Completed NYU Langone Health 1999-07-31
NCT00005278 Retrovirus Epidemiology Donor Study I (REDS I) https://ClinicalTrials.gov/show/NCT00005278 Completed National Heart, Lung, and Blood Institute (NHLBI) 2007-10-31
NCT00005309 Prospective Study of HIV Infection in Hemophiliacs https://ClinicalTrials.gov/show/NCT00005309 Completed Bloodworks 1995-03-31
NCT00005274 Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) https://ClinicalTrials.gov/show/NCT00005274 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005303 Effectiveness of AIDS Antibody Screening https://ClinicalTrials.gov/show/NCT00005303 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005273 Pulmonary Complications of HIV Infection Study (PACS) https://ClinicalTrials.gov/show/NCT00005273 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005301 Transfusion Safety Study (TSS) https://ClinicalTrials.gov/show/NCT00005301 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005229 HIV-Associated Heart Disease https://ClinicalTrials.gov/show/NCT00005229 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005228 AIDS-Associated Heart Disease – Incidence and Etiology https://ClinicalTrials.gov/show/NCT00005228 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005227 AIDS-Associated Cardiomyopathy https://ClinicalTrials.gov/show/NCT00005227 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001650 Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT00001650 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001560 Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers https://ClinicalTrials.gov/show/NCT00001560 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001611 Immune Activity Against CVM Retinitis https://ClinicalTrials.gov/show/NCT00001611 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001500 Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits https://ClinicalTrials.gov/show/NCT00001500 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001353 Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs https://ClinicalTrials.gov/show/NCT00001353 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000168 Longitudinal Study of Ocular Complications of AIDS (LSOCA) https://ClinicalTrials.gov/show/NCT00000168 Completed Johns Hopkins Bloomberg School of Public Health 2013-08-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02797093 Impact of ART Adherence on HIV Persistence and Inflammation https://ClinicalTrials.gov/show/NCT02797093 Active, not recruiting University of Colorado, Denver 2020-10-31
NCT02264509 Peripheral Arterial Insufficiency Associated With HIV/AIDS https://ClinicalTrials.gov/show/NCT02264509 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2014-11-30
NCT01997359 Multi-level Determinants of Starting ART Late: Aim 3 https://ClinicalTrials.gov/show/NCT01997359 Completed Columbia University 2014-04-30
NCT01992887 Pre-ART Retention in Care in Tanzania https://ClinicalTrials.gov/show/NCT01992887 Completed Columbia University 2014-08-31
NCT01908660 Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions https://ClinicalTrials.gov/show/NCT01908660 Completed Valme University Hospital 2015-09-30
NCT01904877 Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men —Test, Link and Care (TLC) https://ClinicalTrials.gov/show/NCT01904877 Completed Vanderbilt University Medical Center 2015-05-31
NCT04333953 COVID-19 in Patients With HIV https://ClinicalTrials.gov/show/NCT04333953 Recruiting University of Missouri-Columbia 2020-10-01
NCT03979144 Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening https://ClinicalTrials.gov/show/NCT03979144 Completed The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 2019-01-26
NCT03690063 Nice Human Immunodeficiency Virus (HIV) Cohort https://ClinicalTrials.gov/show/NCT03690063 Recruiting Centre Hospitalier Universitaire de Nice 1996-01-31
NCT01137981 Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects https://ClinicalTrials.gov/show/NCT01137981 Recruiting ViiV Healthcare 2024-12-31